Assessing SPP1/Osteopontin (OPN) Splice Variants and Their Association to Nonmelanoma Skin Cancer by Absolute Quantification: Identification of OPN-5 Subvariants and Their Protein Coding Potential

Cancer Invest. 2021 Jul-Aug;39(6-7):559-570. doi: 10.1080/07357907.2021.1933015. Epub 2021 Jun 14.

Abstract

The study evaluated whether SPP1/osteopontin (OPN) splice variants are differentially expressed in nonmelanoma skin cancer compared to normal skin. The absolute number of mRNA molecules of OPN-a predominated in normal skin and nonmelanoma skin cancer compared to OPN-b, OPN-c, and OPN-5. However, mRNAs of OPN-a, OPN-b, and OPN-c were expressed in higher levels in cutaneous squamous cell carcinomas (cSCCs) and basal cell carcinomas relative to normal skin. Additionally, OPN-5 expression was higher than OPN-b and OPN-c, and OPN-c, in normal skin and nonmelanoma skin cancer, respectively. Furthermore, we identified four OPN-5 splice variants, which were cloned and analyzed for protein expression.

Keywords: OPN-5 subvariants; Osteopontin; absolute quantification; alternatively spliced variants; basal cell carcinoma; cutaneous squamous cell carcinoma.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alternative Splicing*
  • Carcinoma, Basal Cell / genetics*
  • Carcinoma, Basal Cell / metabolism
  • Carcinoma, Squamous Cell / genetics*
  • Carcinoma, Squamous Cell / metabolism
  • Cell Line, Tumor
  • Cloning, Molecular
  • Female
  • Gene Expression Regulation, Neoplastic
  • Genetic Variation
  • Humans
  • Male
  • Middle Aged
  • Osteopontin / genetics
  • Osteopontin / metabolism*
  • RNA Isoforms / metabolism
  • Skin Neoplasms / genetics*
  • Skin Neoplasms / metabolism
  • Up-Regulation

Substances

  • RNA Isoforms
  • SPP1 protein, human
  • Osteopontin